Specialized rectal cancer care with neoadjuvant chemoradiation, total mesorectal excision, and comprehensive multidisciplinary management for optimal outcomes.
Expert management of rectal cancer with neoadjuvant chemoradiation, total mesorectal excision (TME), and comprehensive multidisciplinary care. We specialize in organ preservation and sphincter-sparing approaches.
MRI pelvis, endoscopic ultrasound, and CT staging for accurate TME planning and circumferential margin assessment.
KRAS, NRAS, BRAF, MSI testing, and comprehensive genomic profiling for treatment selection.
TNM staging, tumor regression grade, lymph node evaluation, and circumferential margin status.
Diarrhea/constipation, narrower stools, urgency, or a feeling of incomplete evacuation.
Blood in stool, mucus, tenesmus; iron-deficiency anemia causing fatigue.
Cramping, pain, unexplained weight loss, and weakness.
Lynch syndrome, FAP; strong family history; personal history of polyps/IBD.
High red/processed meat intake, obesity, smoking, alcohol, physical inactivity.
Risk increases after 50; type 2 diabetes and metabolic syndrome add risk.
Regular CEA monitoring, CT scans, colonoscopy, and digital rectal examination for recurrence detection.
Collaboration with colorectal surgery, radiation oncology, and gastroenterology specialists.
Managing treatment side effects, bowel function, and maintaining quality of life post-treatment.